JMP Securities Raises CRISPR Therapeutics (NASDAQ:CRSP) Price Target to $80.00
CRISPR Therapeutics (NASDAQ:CRSP – Free Report) had its target price raised by JMP Securities from $74.00 to $80.00 in a report released on Monday, Benzinga reports. They currently have a market outperform rating on the stock. A number of other research firms also recently weighed in on CRSP. Truist Financial restated a buy rating on […]
More Stories
Two Sigma Advisers LP Sells 191,000 Shares of Element Solutions Inc (NYSE:ESI)
Two Sigma Advisers LP cut its holdings in shares of Element Solutions Inc (NYSE:ESI – Free Report) by 77.9% during...
Ulta Beauty’s (ULTA) “Neutral” Rating Reaffirmed at Piper Sandler
Piper Sandler reiterated their neutral rating on shares of Ulta Beauty (NASDAQ:ULTA – Free Report) in a research report released...
Elastic (NYSE:ESTC) Price Target Cut to $120.00 by Analysts at Piper Sandler
Elastic (NYSE:ESTC – Free Report) had its price target reduced by Piper Sandler from $135.00 to $120.00 in a report...
Brokerages Set NVIDIA Co. (NASDAQ:NVDA) PT at $167.53
NVIDIA Co. (NASDAQ:NVDA – Get Free Report) has received an average recommendation of “Moderate Buy” from the forty-four research firms...
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Position in Flutter Entertainment plc (NYSE:FLUT)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Flutter Entertainment plc (NYSE:FLUT – Free Report) by 163.7% in...
Artesian Resources Co. (NASDAQ:ARTNA) Shares Sold by Millennium Management LLC
Millennium Management LLC decreased its stake in Artesian Resources Co. (NASDAQ:ARTNA – Free Report) by 24.4% in the 4th quarter,...